Multiple Myeloma
Understanding eligibility criteria for clinical research studies
Clinical trials utilize sets of criteria to determine if a person is a good fit - but what are these and what do they mean?
When researching clinical trials for cancer, it is helpful to have an understanding of the types of information that is needed to determine whether someone is a fit or not. This information is called eligibility criteria and is typically made up of different types of data points and acceptable ranges. While some trials utilize criteria that are fairly straightforward, cancer study criteria tend to be a bit more comprehensive and complex.
Eligibility criteria for a given trial are set by the entity sponsoring the trial, which could be drug manufacturer or medical university. Criteria are based on the specifics of what the trial and its physician investigators are evaluating (called an end-point or an outcome measure). Inclusion criteria reflect attributes that a potential participant must match to; exclusion criteria are the opposite and reflect attributes a potential participant should lack in terms of medical history.
When reading a trial overview related to a cancer, eligibility criteria will likely start out with straightforward requirements such as age, gender and possible weight requirements. The primary diagnosis will also be noted. Sometimes this is very specific to specific cancer subtypes. For example, a breast cancer patient interested in clinical research may search for the condition broadly and find trials requiring a diagnosis of HER2+ or triple negative breast cancer. It will be helpful to have biomarker information when undertaking trial searches. Biomarkers include proteins or genes that can be found in tumors and may offer specific treatment options in the realm of clinical research.
Other inclusion criteria will reference additional and unique factors related to the type of cancer (i.e., any metastases, prognosis) as well as the general overall health status of the patient.
For a patient that has had previous cancer treatment or has additional medical issues, a close review of exclusion criteria is important. These are factors that prevent someone from entering a trial, most likely due to safety concerns. Since trials are essentially trying to evaluate the effectiveness of a therapy, it is important that participants fit the same profile. This helps with drawing conclusions and extrapolating to larger populations.
Exclusion criteria related to cancer trials may be a long list and will likely include items around:
- Timeframe and type of previous cancer treatment
- Presence of uncontrolled chronic illness
- History of surgeries
- Pregnancy and lactation status
- Any consistently out-of-range lab test results
It can be emotionally tiring to spend time researching trials only to find that there are no good matches based on eligibility criteria. However, cancer trials do open on a regular basis, each with their own unique criteria. Over time a patient's "fit" to criteria may evolve as well. For a person interested in clinical research as a care option, registering for access to medical records through a patient portal can make it easier to review data and latest results, trends and clinical notes.
Interested in learning more about clinical research options for different cancer types? Take a look at trials that are currently seeking participants by clicking here.
Published Date April 05, 2023
Latest News
Multiple Myeloma
Life with a rare disease
Experiencing serious health challenges is difficult enough - having a relatively unknown condition adds additional complexity
2024-07-08T22:02:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Speaking with your PCP about MASH
Engaging your primary doctor in a conversation about risk for MASH liver disease doesn't have to be scary
2024-06-25T12:15:00Z
Alzheimer's Disease
New Alzheimer’s Disease research breakthroughs
The 2020s have been the most impactful decade so far for the debilitating form of dementia
2024-05-02T18:30:00Z
Breast Cancer
Talking to family about cancer genes
Though this conversation may be difficult, it might be vitally important for your loved ones
2024-02-05T18:30:00Z
Lupus
Lupus (Systemic Lupus Erythematosus) and Diet
Can what you eat make a difference?
2024-04-15T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Learning you need a liver biopsy: staying calm
Approaches to stay in control before, during and after a biopsy
2023-12-27T18:30:00Z
Diabetes
The recent rise of walking as exercise
Grab your sneakers, grab a friend, or grab your dog and get moving!
2023-12-05T18:30:00Z
Renal Cell Carcinoma
Coping with the holidays during cancer treatment
Getting ready to face a new year while facing cancer is no easy task
2023-11-23T18:30:00Z
Multiple Sclerosis (MS)
Possible link between multiple sclerosis and viral infection?
Researchers are looking to learn more about if and how a virus can trigger multiple sclerosis
2023-10-25T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Making lifestyle changes: ten ideas to get started
Losing excess weight together with an active lifestyle helps with the management of MASH, but where to begin?
2023-09-05T18:30:00Z
Lung Cancer
Talking to loved ones about your clinical trial
How to talk to family and friends when you are thinking of changing cancer treatment plans for a research option
2023-08-14T18:30:00Z
Lung Cancer
Learning you have lung cancer as a non-smoker
Lung cancer can be a shocking diagnosis when you've never smoked - how can it be?
2023-08-15T18:30:00Z
Prostate Cancer
Does a high PSA score always mean cancer?
Learn more about this common test for older men and how it relates to cancer risk
2023-07-10T18:30:00Z
Breast Cancer
Understanding the differences between mastectomy and lumpectomy
Two different surgical options both seeking the same outcome
2023-07-07T18:30:00Z
Lupus
New treatments are on the horizon for lupus patients
From biologics to CAR-T, developments in clinical research for SLE have opened new treatment doors for patients.
2023-05-22T16:15:00Z
Multiple Myeloma
Understanding eligibility criteria for clinical research studies
Clinical trials utilize sets of criteria to determine if a person is a good fit - but what are these and what do they mean?
2023-04-05T18:30:00Z
Renal Cell Carcinoma
Learning you need a biopsy: staying calm
Approaches to stay in control before, during and after a diagnostic biopsy
2023-03-14T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Making lifestyle changes: ten ideas to get started
Pharmaceutical companies are rushing to fill the NASH treatment gap
2023-03-14T18:30:00Z